Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein

Adrian C Apetri1, David L Vanik, Witold K Surewicz

  • 1Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106, USA.

Biochemistry
|November 30, 2005
PubMed

Insights

Familial prion disease mutations alter human prion protein (huPrP) biophysical properties. The D178N mutation significantly increases conversion to amyloid fibrils, with M/V polymorphism at residue 129 critically influencing this process.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Transmissible spongiform encephalopathies (TSEs) are linked to prion protein (PrP) mutations.
  • The PRNP gene harbors mutations causing inherited prion diseases, such as fatal familial insomnia and familial Creutzfeldt-Jakob disease.
  • The Asp178Asn (D178N) mutation in PRNP is associated with distinct phenotypes based on methionine (Met) or valine (Val) at codon 129.

Purpose of the Study:

  • To investigate the biophysical properties of human prion protein (huPrP90-231) variants with the D178N mutation.
  • To determine the impact of the methionine/valine (M/V) polymorphism at codon 129 on the D178N huPrP variant's conversion propensity and amyloid formation.

Main Methods:

  • Recombinant human prion proteins (huPrP90-231) corresponding to D178N/M129 and D178N/V129 polymorphic variants were characterized.
  • Biophysical properties, including conversion to beta-sheet-rich oligomers and amyloid fibrils, were assessed at acidic and neutral pH.
  • Thioflavine T fluorescence was used to detect amyloid fibril formation.
  • Secondary structures of wild-type and variant amyloid fibrils were analyzed.

Main Results:

  • Both D178N/M129 and D178N/V129 huPrP variants exhibited a significantly increased propensity for conversion to beta-sheet-rich oligomers and amyloid fibrils compared to wild-type huPrP.
  • The conversion propensity of the D178N variant was highly dependent on the M/V polymorphism at codon 129.
  • Wild-type huPrP showed no such dependence on the M/V polymorphism under identical conditions.
  • Amyloid fibrils formed by wild-type and D178N variants displayed distinct secondary structures, further modulated by the codon 129 polymorphism.

Conclusions:

  • The D178N mutation in the PRNP gene markedly enhances the propensity of huPrP to form amyloidogenic species.
  • The M/V polymorphism at codon 129 of PRNP plays a critical role in modulating the biophysical properties and conversion behavior of the D178N PrP variant.
  • These polymorphism-dependent biophysical differences provide a potential molecular basis for the distinct clinical phenotypes observed in familial prion diseases.

Related Concept Videos

Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.